发明名称 |
Pharmaceutical composition for treating a metabolic syndrome |
摘要 |
The invention is directed to a pharmaceutical composition containing at least one FGF-21 (fibroblast growth factor 21) compound, at least one GLP-1R (glucagon-like peptide-1 receptor) agonist and optionally at least one anti-diabetic drug and/or at least one DPP-4 (dipeptidyl peptidase-4) inhibitor for the treatment of at least one metabolic syndrome and/or atherosclerosis, in particular diabetes, dyslipidemia, obesity and/or adipositas. |
申请公布号 |
AU2011208650(B2) |
申请公布日期 |
2016.07.14 |
申请号 |
AU20110208650 |
申请日期 |
2011.01.21 |
申请人 |
SANOFI |
发明人 |
SOMMERFELD, MARK;SCHAEFER, HANS-LUDWIG;BOSCHEINEN, OLIVER;HABERMANN, PAUL;RAO, ERCOLE;DREYER, MATTHIAS |
分类号 |
A61K38/18;A61K38/26;A61P3/00 |
主分类号 |
A61K38/18 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|